Article
NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation - 1 Aug 2011
van der Straaten Hanneke M, Paquay Martine M, Tilanus Marcel G J, van Geloven Nan, Verdonck Leo F, Huisman Cynthia
Abstract excerpt
Single nucleotide polymorphisms (SNPs) in the innate immunity receptor NOD2/CARD15 have been demonstrated to modulate the outcome of allogeneic hematopoietic stem cell transplantation (SCT). The effect of NOD2/CARD15 polymorphism is reported to be associated with type of donor (sibling or matched unrelated donor) as well as type of conditioning regimen. We reviewed NOD2/CARD15 SNPs in all donor/recipient pairs of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
